Translated automatically – community improvements welcome.
GABA-A Agonist
Gaboxadol (THIP) is a selective GABA-A receptor agonist that primarily acts on extrasynaptic α4β3δ receptors, thereby exhibiting sleep-promoting and anxiolytic effects. It was originally developed as a potential sleep aid but did not achieve widespread clinical use due to side effects and safety concerns. The substance influences neuronal inhibition and can dampen consciousness without manifesting classical benzodiazepine-like effects.
Mechanism of Action
- GABA-A agonist
Names / Identifiers
IUPAC: Gaboxadol (THIP)
Effects
Effects described from scientific sources. Individual experiences vary.
Dosage
Individual sensitivity varies. Not a dosage recommendation.
Duration
Risks & Warnings
Warnings
- Pregnancy
- Breastfeeding
- Severe liver disease
Known Risks
- medium
- Mögliche Nebenwirkungen umfassen Schläfrigkeit, Schwindel und kognitive Beeinträchtigungen.
Safer Use
- Start with a low dose.
- Do not combine with alcohol or other sedatives.
Harm reduction tips do not replace medical advice.
Known Interactions
- Alcohol
- Benzodiazepines
- Opioids
This list is not exhaustive. Interactions can have unpredictable effects.
Legal Status
Not legal advice. Status may change.